PHI with Renal glycinuria
How does this condition affect your private health insurance?
Renal Glycinuria is a rare, inherited metabolic disorder characterized by impaired reabsorption of glycine in the renal tubules, leading to excessive excretion of glycine in the urine. This condition is usually benign and often asymptomatic, meaning individuals may never experience symptoms or require specific treatment. It's typically diagnosed incidentally through urine amino acid analysis. While the condition itself is harmless, in very rare instances, the elevated urinary glycine levels, particularly when combined with other predisposing factors like hyperoxaluria, could theoretically increase the propensity for calcium oxalate kidney stone formation. However, this is not a common complication, and the disorder is generally considered benign.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Lifelong, present from birth, though symptoms (if any) are rare and usually develop later in life (e.g., kidney stones).
Duration of Illness (Lifetime)
Chronic, lifelong condition.
Cost of Treatment (Initial)
Minimal, primarily diagnostic testing (urine amino acid analysis). No specific treatment is usually required at first occurrence.
Cost of Treatment (Lifetime)
Low, mainly monitoring for kidney stones if symptomatic. No specific ongoing medication or treatment for the glycinuria itself.
Mortality Rate
Extremely low; Renale Glyzinurie itself is not directly life-threatening.
Risk of Secondary Damages
Very low; primarily a slightly increased risk of calcium oxalate kidney stones in rare cases, especially if combined with hyperoxaluria or other stone-forming conditions. No direct physical or psychological damage.
Probability of Full Recovery
0%; it is a genetic, lifelong metabolic condition from which one does not recover.
Underlying Disease Risk
Very low; it is often an isolated metabolic finding. Rarely, it might be associated with other genetic syndromes affecting renal transport, but this is not typical.